Mammary Microvessels are Sensitive to Menstrual Cycle Sex Hormones
Advanced Science · 2023
DOI: 10.1002/advs.202302561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Carmen Moccia und 6 weiteren Autor:innen. Beteiligte Einrichtung: European Molecular Biology Laboratory, Barcelona, Dr. Aiguader, 88, Barcelona, 08003, Spain. Hauptthemen laut MEDLINE: Menstrual Cycle, Progesterone. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Molecular Biology Laboratory.
Abstract (Originalsprache)
The mammary gland is a highly vascularized organ influenced by sex hormones including estrogen (E2) and progesterone (P4). Beyond whole‐organism studies in rodents or cell monocultures, hormonal effects on the breast microvasculature remain largely understudied. Recent methods to generate 3D microvessels on‐chip have enabled direct observation of complex vascular processes; however, these models often use non‐tissue‐specific cell types, such as human umbilical vein endothelial cells (HUVECs) and fibroblasts from various sources. Here, novel mammary‐specific microvessels are generated by coculturing primary breast endothelial cells and fibroblasts under optimized culture conditions. These microvessels are mechanosensitive (to interstitial flow) and require endothelial–stromal interactions to develop fully perfusable vessels. These mammary‐specific microvessels are also responsive to exogenous stimulation by sex hormones. When treated with combined E2 and P4, corresponding to the four phases of the menstrual cycle (period, follicular, ovular, and luteal), vascular remodeling and barrier function are altered in a phase‐dependent manner. The presence of high E2 (ovulation) promotes vascular growth and remodeling, corresponding to high depletion of proangiogenic factors, whereas high P4 concentrations (luteal) promote vascular regression. The effects of combined E2 and P4 hormones are not only dose‐dependent but also tissue‐specific, as are shown by similarly treating non‐tissue‐specific HUVEC microvessels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- European Molecular Biology Laboratory, Barcelona, Dr. Aiguader, 88, Barcelona, 08003, Spain.
- Heidelberg University, Heidelberg, Germany.
ORCID-Profile: Carmen Moccia, Marta Cherubini, Marina Fortea, Akinola Akinbote, Violeta Beltran-Sastre, Kristina Haase
Förderung
- European Molecular Biology Laboratory
Zitieren
APA
Moccia, C., Cherubini, M., Fortea, M., Akinbote, A., Padmanaban, P., Beltran-Sastre, V., & Haase, K. (2023). Mammary Microvessels are Sensitive to Menstrual Cycle Sex Hormones. Advanced Science. https://doi.org/10.1002/advs.202302561
Vancouver
Moccia C, Cherubini M, Fortea M, Akinbote A, Padmanaban P, Beltran-Sastre V, et al. Mammary Microvessels are Sensitive to Menstrual Cycle Sex Hormones. Advanced Science. 2023. doi:10.1002/advs.202302561
BibTeX
@article{Moccia2023,
author = {Moccia, Carmen and Cherubini, Marta and Fortea, Marina and Akinbote, Akinola and Padmanaban, Prasanna and Beltran-Sastre, Violeta and Haase, Kristina},
title = {Mammary Microvessels are Sensitive to Menstrual Cycle Sex Hormones},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202302561}
}
EUVIMED